[Blue Skys]

I thought the rally had started but the OS increased by almost 280M shares. Do you think that those shares were sold into the market or dispensed to accomodate note conversions? I'm surprised that if they needed cash they didn't sell some of their AXIM shares. That's an interesting data point. Nevertheless this could have been obligatory note conversions. What do you think?

[Dean14]

Has the Rally started yet?

[1vman]

*****Doesn't look like theres going be an MJ sector run this year !!! So MJNA will remain stagnant for the rest of the year IMO ( In My Opinion ) LOL

WHOOPS

ENOUGH SAID

[scoobey-do]

Interesting video regarding colon cancer and marijuana. Worth a listen.

[KICK1]

A Blast From The Past! $MJNA 420

[Rat Fink]

IS MJNA LAUNCHING AGAIN YET?? HOW HIGH_WILL_MJNA_GO_THIS_TIME?_.05_.10,.15,.20,.25_OR_HIGHER??

IN MY OPINION



*****FEBRUARY 11, 2021, MJNA HIT 22.2 CENTS ON FEBRUARY 11, 2011!!!



*****LAST MJNA RUN!!! .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_GAIN_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



SOURCE OF 1/24/22 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[1vman]

*****Doesn't look like theres going be an MJ sector run this year !!! So MJNA will remain stagnant for the rest of the year IMO ( In My Opinion ) LOL

WHOOPS

ENOUGH SAID

[Rat Fink]

I THINK MJ STOCKS & MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!

MJNA HIT 22.2 CENTS_2021!!!

HOW HIGH WILL MJNA_GO_NEXT_BIG_RUN???_5¢_10¢_15¢_20¢_25¢_OR_HIGHER???

IN MY OPINION



*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!

MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****

LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical

.268/.0275 = 9.75 TIMES!!!...



SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[Rat Fink]

WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???

IN 2015, A PREVIOUS MJNA CEO STUART TITUS INDICATED THEY'LL ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!

EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:

"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."

SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/

[Rat Fink]

PER 3-14-23 PR, NEW MJNA CEO; RENEWED_ FOCUS_ON_PROFITABILITY_+_EXPANSION!!!_https://finance.yahoo.com/news/medical-marijuana-inc-appoints-ceo-130000182.html

EXCERPT BELOW FROM LINKED PR:

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion

World’s First-Ever Publicly Traded Cannabis Company Appoints Longtime Board Member as New CEO

SAN DIEGO, CA , March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in companies in the biotechnology industry, announced today the appointment of Dr. Timothy R. Scott as its new Chief Executive Officer, President, and Chairman of the Board. Dr. Scott takes the helm of the organization after serving on the Company’s board since 2015, as well as for several years on the Boards of both of the entities that comprise the Company's investment holdings, signaling a thorough understanding of the Company's operating subsidiaries and portfolio investments. Dr. Scott had recently taken an advisory role within the Company, having accepted a position as the Chief People Officer, before accepting this new role of CEO.

Dr. Scott’s appointment follows the acceptance by the Board of Directors of the resignation of Blake N. Schroeder who served as the Company’s CEO, President and Chairman of the Board since 2021 and served in other executive roles going back to 2016. Mr. Schroeder will continue to serve on the boards of the Company’s portfolio investments; Axim Biotechnologies, Inc. (OTCQB: AXIM) and Neuropathix, Inc. (OTCQB: NPTX). In addition, he will provide consulting and advisory services to Neuropathix.

"I want to personally thank Blake for his many years of service and dedication to our organization,” newly appointed CEO of Medical Marijuana, Inc. Dr. Timothy R Scott said. "We are pleased that he will remain a part of the MJNA family through his board memberships with our portfolio investments and his advisory role with Neuropathix, which we believe can be significantly supported and advanced by Blake's involvement and his contacts in the biotech space.”

Dr. Scott added: “Our Company, along with other companies in the state and federally legal cannabis business, has faced increased competition that has lead to decreasing sales and tighter margins. We expect to see substantial consolidation in the industry and are positioning the Company to take advantage of this by undertaking significant financial and operational restructuring efforts to increase efficiencies, preserve and increase cash flow, incentivize key employees, and increase our portfolio investments. I believe these efforts will enable the Company to grow more quickly and profitably as we move forward. We have among the highest quality products in the industry, a diversified distribution platform, with significant barriers to entry for would-be competitors, and experienced leaders in our two key operating subsidiaries, HempMeds and Kannaway. In addition, the Company believes that its portfolio investments Neuropathix, Inc. (symbol; NPTX) and Axim Biotechnologies, Inc. (Symbol: AXIM) have significant untapped value, and we continue to be extremely positive for the outlook of these companies and their respective technology and intellectual property.”

Headquartered in Vista, California, Medical Marijuana Inc. is the first-ever publicly traded cannabis company in the United States that launched the world’s first cannabis-derived nutraceutical products, brands and supply chain, and remains one of the world’s leading manufacturers and suppliers of hemp-derived CBD. Its portfolio of operating assets includes HempMeds, which was the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and continues to expand its market share in those regions, as well as Kannaway, the world’s first direct selling company dedicated to the hemp CBD wellness space. Since its inception, Kannaway has expanded to over 40 countries and directly impacts the lives of thousands of brand ambassadors through its value-build sales platform. Beyond these operating assets, Medical Marijuana Inc. holds significant debt and equity investments in two companies in the biotechnology space (Axim Biotechnologies, Inc. and Neuropathix, Inc.).

About Medical Marijuana, Inc.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with two distinct operating business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp. Medical Marijuana, Inc. was named a top CBD producer by CNBC and was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. In addition, as a result of its holdings in Neuropathix, Inc. the Company is invested in cannabinoid-based clinical research and botanical drug development. Also, the Company has significant holdings in AXIM® Biotechnologies, Inc., which is engaged in the manufacture and sale of FDA-cleared dry eye disease (DED) diagnostic tests and recently filed a patent for a fentanyl neutralizing antibody test that may have application in reducing fentanyl overdose deaths.

Medical Marijuana, Inc.'s headquarters is in Vista, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.

[Rat Fink]

LAST HUGE MJNA RUN!! .222(2-11-21HIGH)/.0106(2-28-20LOW)_OR_21_TIMES_GAIN_IN_~1_YR_***

MJNA HIGH ON 2-11-21 HIGH: .222
MJNA LOW ON 2-28-20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



SOURCE OF 1/24/22 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[Rat Fink]

NUMEROUS MJNA RUNS NOTED IN MJNA_10-YR_CHART_BELOW_INCLUDING:_24X,_21X,_10X,_6X!!!

BASED ON THE BELOW ANNOTATED OLD 10-YR. MJNA CHART DATED 1/24/22 BELOW:

[Rat Fink]

3/10/22 ARTICLE, MJNA SATISFIES TWO_MAJOR_O/S_DEBT_LIABILITIES!!!_https://seekingalpha.com/news/3812158-medical-marijuana-satisfies-2-major-outstanding-debt-liabilities?utm_source=advfn.com&utm_medium=referral

[Dean14]

Speak for yourself

[Skaff]

It's time to cut our losses and take the write off. MJNA is done.

[KICK1]

Agreed

[Saving Grace]

Short selling away scam, ending. Banks crashing, arrests imminent.

Short selling scam banks are not Basil III compliant and will all be closed.

The Debt ceiling head fake will close many more. 4800 have already closed
in the U.S. alone. Hedge Funds are going to follow. The manipulation racket
of money laundering days, is over soon.

QFS has them all cornered with no place to run.

All Pot stocks are soon to spike!

[1vman]

*****Doesn't look like theres going be an MJ sector run this year !!! So MJNA will remain stagnant for the rest of the year IMO ( In My Opinion ) LOL

WHOOPS

ENOUGH SAID

[Rat Fink]

I THINK MJ STOCKS & MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!

MJNA HIT 22.2 CENTS_2021!!!

HOW HIGH WILL MJNA_GO_NEXT_BIG_RUN???_5¢_10¢_15¢_20¢_25¢_OR_HIGHER???

IN MY OPINION



*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!

MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****

LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical

.268/.0275 = 9.75 TIMES!!!...



SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[Dean14]

https://mailchi.mp/1379246b5145/ushr-urges-congressional-action-in-response-to-fdas-misguided-promotion-of-incomplete-cbd-safety-data?e=2aab825e96

[1vman]

*****Doesn't look like theres going be an MJ sector run this year !!! So MJNA will remain stagnant for the rest of the year IMO ( In My Opinion ) LOL

WHOOPS

ENOUGH SAID

[Rat Fink]

I THINK MJ STOCKS & MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!

MJNA HIT 22.2 CENTS_2021!!!

HOW HIGH WILL MJNA_GO_NEXT_BIG_RUN???_5¢_10¢_15¢_20¢_25¢_OR_HIGHER???

IN MY OPINION



*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!

MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****

LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical

.268/.0275 = 9.75 TIMES!!!...



SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[Rat Fink]

WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???

IN 2015, A PREVIOUS MJNA CEO STUART TITUS INDICATED THEY'LL ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!

EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:

"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."

SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/

[Rat Fink]

3/10/22 ARTICLE, MJNA SATISFIES TWO_MAJOR_O/S_DEBT_LIABILITIES!!!_https://seekingalpha.com/news/3812158-medical-marijuana-satisfies-2-major-outstanding-debt-liabilities?utm_source=advfn.com&utm_medium=referral

[Dean14]

Looks like a Rally coming this year as we get closer to the Farm Bill.

[1vman]

*****Doesn't look like theres going be an MJ sector run this year !!! So MJNA will remain stagnant for the rest of the year IMO ( In My Opinion ) LOL

WHOOPS

ENOUGH SAID

[Rat Fink]

I THINK MJ STOCKS & MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!

MJNA HIT 22.2 CENTS_2021!!!

HOW HIGH WILL MJNA_GO_NEXT_BIG_RUN???_5¢_10¢_15¢_20¢_25¢_OR_HIGHER???

IN MY OPINION



*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!

MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****

LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical

.268/.0275 = 9.75 TIMES!!!...



SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[Rat Fink]

PER 3-14-23 PR, NEW MJNA CEO; RENEWED_ FOCUS_ON_PROFITABILITY_+_EXPANSION!!!_https://finance.yahoo.com/news/medical-marijuana-inc-appoints-ceo-130000182.html

EXCERPT BELOW FROM LINKED PR:

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion

World’s First-Ever Publicly Traded Cannabis Company Appoints Longtime Board Member as New CEO

SAN DIEGO, CA , March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in companies in the biotechnology industry, announced today the appointment of Dr. Timothy R. Scott as its new Chief Executive Officer, President, and Chairman of the Board. Dr. Scott takes the helm of the organization after serving on the Company’s board since 2015, as well as for several years on the Boards of both of the entities that comprise the Company's investment holdings, signaling a thorough understanding of the Company's operating subsidiaries and portfolio investments. Dr. Scott had recently taken an advisory role within the Company, having accepted a position as the Chief People Officer, before accepting this new role of CEO.

Dr. Scott’s appointment follows the acceptance by the Board of Directors of the resignation of Blake N. Schroeder who served as the Company’s CEO, President and Chairman of the Board since 2021 and served in other executive roles going back to 2016. Mr. Schroeder will continue to serve on the boards of the Company’s portfolio investments; Axim Biotechnologies, Inc. (OTCQB: AXIM) and Neuropathix, Inc. (OTCQB: NPTX). In addition, he will provide consulting and advisory services to Neuropathix.

"I want to personally thank Blake for his many years of service and dedication to our organization,” newly appointed CEO of Medical Marijuana, Inc. Dr. Timothy R Scott said. "We are pleased that he will remain a part of the MJNA family through his board memberships with our portfolio investments and his advisory role with Neuropathix, which we believe can be significantly supported and advanced by Blake's involvement and his contacts in the biotech space.”

Dr. Scott added: “Our Company, along with other companies in the state and federally legal cannabis business, has faced increased competition that has lead to decreasing sales and tighter margins. We expect to see substantial consolidation in the industry and are positioning the Company to take advantage of this by undertaking significant financial and operational restructuring efforts to increase efficiencies, preserve and increase cash flow, incentivize key employees, and increase our portfolio investments. I believe these efforts will enable the Company to grow more quickly and profitably as we move forward. We have among the highest quality products in the industry, a diversified distribution platform, with significant barriers to entry for would-be competitors, and experienced leaders in our two key operating subsidiaries, HempMeds and Kannaway. In addition, the Company believes that its portfolio investments Neuropathix, Inc. (symbol; NPTX) and Axim Biotechnologies, Inc. (Symbol: AXIM) have significant untapped value, and we continue to be extremely positive for the outlook of these companies and their respective technology and intellectual property.”

Headquartered in Vista, California, Medical Marijuana Inc. is the first-ever publicly traded cannabis company in the United States that launched the world’s first cannabis-derived nutraceutical products, brands and supply chain, and remains one of the world’s leading manufacturers and suppliers of hemp-derived CBD. Its portfolio of operating assets includes HempMeds, which was the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and continues to expand its market share in those regions, as well as Kannaway, the world’s first direct selling company dedicated to the hemp CBD wellness space. Since its inception, Kannaway has expanded to over 40 countries and directly impacts the lives of thousands of brand ambassadors through its value-build sales platform. Beyond these operating assets, Medical Marijuana Inc. holds significant debt and equity investments in two companies in the biotechnology space (Axim Biotechnologies, Inc. and Neuropathix, Inc.).

About Medical Marijuana, Inc.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with two distinct operating business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp. Medical Marijuana, Inc. was named a top CBD producer by CNBC and was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. In addition, as a result of its holdings in Neuropathix, Inc. the Company is invested in cannabinoid-based clinical research and botanical drug development. Also, the Company has significant holdings in AXIM® Biotechnologies, Inc., which is engaged in the manufacture and sale of FDA-cleared dry eye disease (DED) diagnostic tests and recently filed a patent for a fentanyl neutralizing antibody test that may have application in reducing fentanyl overdose deaths.

Medical Marijuana, Inc.'s headquarters is in Vista, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.

[Rat Fink]

LAST HUGE MJNA RUN!! .222(2-11-21HIGH)/.0106(2-28-20LOW)_OR_21_TIMES_GAIN_IN_~1_YR_***

MJNA HIGH ON 2-11-21 HIGH: .222
MJNA LOW ON 2-28-20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



SOURCE OF 1/24/22 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[Rat Fink]

NUMEROUS MJNA RUNS NOTED IN MJNA_10-YR_CHART_BELOW_INCLUDING:_24X,_21X,_10X,_6X!!!

BASED ON THE BELOW ANNOTATED OLD 10-YR. MJNA CHART DATED 1/24/22 BELOW:

[Rat Fink]

WILL MJNA ENTER LEGAL MJ_MARKET_IF_MJ_BECOMES_LEGAL???

IN 2015, A PREVIOUS MJNA CEO STUART TITUS INDICATED THEY'LL ENTER_LEGAL_MJ_MARKET_IF_MJ_BECOMES_LEGAL!!!

EXCERPT FROM "LETTER TO SHAREHOLDERS BY A PREVIOUS MJNA CEO STUART TITUS", 5/14/15, AS FOLLOWS:

"...we are poised and consider ourselves well-positioned for eventual cannabis legalization. We have a plan for that eventuality, and intend to leverage our relationships and expertise to help advance a truly legal cannabis industry when the day comes. Once legalization occurs or becomes better defined regarding states rights – we can quickly implement entry into this new market. Rescheduling – if not full de-scheduling – from the Controlled Substances Act would signal the clear demarcation point of our entry into the space."

SOURCE: http://medicalmarijuanainc.com/letter-to-shareholders-by-ceo-stuart-titus-2014-annual-report/

[Rat Fink]

3/10/22 ARTICLE, MJNA SATISFIES TWO_MAJOR_O/S_DEBT_LIABILITIES!!!_https://seekingalpha.com/news/3812158-medical-marijuana-satisfies-2-major-outstanding-debt-liabilities?utm_source=advfn.com&utm_medium=referral

[1vman]

*****MJNA IS OUT_TO_LUNCH!!!_HOW_LOW_WILL IT GO THIS TIME .003 .002 ......

MJNA NEVER HOLDS GAINS !!! TYPICAL OTC STINKY PINKY

ENOUGH SAID

[Rat Fink]

IS MJNA LAUNCHING AGAIN YET?? HOW HIGH_WILL_MJNA_GO_THIS_TIME?_.10,.15,.20,.25_OR_HIGHER??

IN MY OPINION



*****FEBRUARY 11, 2021, MJNA HIT 22.2 CENTS ON FEBRUARY 11, 2011!!!



*****LAST MJNA RUN!!! .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_GAIN_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



SOURCE OF 1/24/22 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical

[1vman]

*****Doesn't look like theres going be an MJ sector run this year !!! So MJNA will remain stagnant for the rest of the year IMO ( In My Opinion ) LOL

WHOOPS

ENOUGH SAID

[JohnCM]

Why is there a reluctance to reverse split shares?

[JohnCM]

I believe the sector flattens out here for a month or so followed by a confirmed reversal.

[JohnCM]

$0.004 to $0.0045 = 12 percent. If held for 2 weeks, is 312 percent annualized.

[Rat Fink]

I THINK MJ STOCKS & MJNA_ARE_DUE_FOR_ANOTHER_BIG_RUN!!!

MJNA HIT 22.2 CENTS_2021!!!

HOW HIGH WILL MJNA_GO_NEXT_BIG_RUN???_5¢_10¢_15¢_20¢_25¢_OR_HIGHER???

IN MY OPINION



*****LAST MJNA RUN MJNA RAN A VERY IMPRESSIVE 21_TIMES_GAIN_IN_~1_YEAR_FROM_.0106_TO_.222!!!

MJNA GAINED .222(2/11/21HIGH)/.0106(2/28/20LOW)_OR_21_TIMES_IN_~1_YR!!!

MJNA HIGH ON 2/11/21 HIGH: .222
MJNA LOW ON 2/28/20 LOW: .0106
.222/.0106 = 20.9 TIMES GAIN
SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical



****A 2015/2016 10 TIMES RUN!!!..._.0275(9/30/15)_TO_.268(11/3/16)!!!****

LOW ON 9/30/15 WAS: .0275
HIGH ON 11/3/16 WAS: .268
MJNA HISTORICAL PPS SOURCE: https://www.nasdaq.com/market-activity/stocks/mjna/historical

.268/.0275 = 9.75 TIMES!!!...



SOURCE OF OLD 10-YR. MJNA CHART PPSs IN ANNOTATED MJNA 1/24/22 10-YR CHART BELOW: https://www.nasdaq.com/market-activity/stocks/mjna/historical